- GlobeNewswire•20 hours ago
ROCKVILLE, Md., April 26, 2017-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ...
- MarketWatch•8 days ago
Harry Boxer sums up what the charts are telling him about these four stocks.
- Investor's Business Daily•9 days ago
Shares of biotech leader Supernus Pharmaceuticals briefly broke out Tuesday, but struggled to remain above that key level of support.
SUPN : Summary for Supernus Pharmaceuticals, Inc. - Yahoo Finance
Supernus Pharmaceuticals, Inc. (SUPN)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||32.75 x 500|
|Ask||32.85 x 600|
|Day's Range||32.65 - 33.35|
|52 Week Range||14.14 - 33.65|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||18.62|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|